Scientists identified a novel AR/AR-V7 degrader and found that ARVib effectively degrades AR/AR-V7 protein and attenuated AR/AR-V7 downstream target gene expression in prostate cancer cells.
[Oncogene]
6445218
{6445218:XRMCC8ZK}
apa
50
1
164687
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
